GOLDENWELL BIOTECH, INC. (GWLL) Gross margin 2021–2025
GOLDENWELL BIOTECH, INC. (GWLL) gross margin by fiscal year — reported gross profit divided by reported revenue.
21.8%FY2025 · since FY2021: 52.5% → 21.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.8% | -24.2 pp |
| FY2024 | 46.0% | +17.6 pp |
| FY2023 | 28.5% | -24.2 pp |
| FY2022 | 52.7% | +0.2 pp |
| FY2021 | 52.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice